<li>aceclofenac<p>aceclofenac will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>acemetacin<p>acemetacin will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>acyclovir<p>celecoxib will increase the level or effect of acyclovir by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>alendronate<p>celecoxib, alendronate.
Either increases toxicity of the other by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of GI ulceration.</p></li><li>amikacin<p>celecoxib increases levels of amikacin by decreasing renal clearance. Minor/Significance Unknown. Interaction mainly occurs in preterm infants.</p></li><li>aminohippurate sodium<p>celecoxib will increase the level or effect of aminohippurate sodium by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>amiodarone<p>amiodarone will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>amobarbital<p>amobarbital will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>anamu<p>celecoxib and anamu both increase  anticoagulation. Minor/Significance Unknown.</p></li><li>aripiprazole<p>celecoxib will increase the level or effect of aripiprazole by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>aspirin<p>aspirin will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>aspirin rectal<p>aspirin rectal will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>aspirin/citric acid/sodium bicarbonate<p>aspirin/citric acid/sodium bicarbonate will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>balsalazide<p>celecoxib will increase the level or effect of balsalazide by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>bendroflumethiazide<p>bendroflumethiazide will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>bosentan<p>bosentan will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>butabarbital<p>butabarbital will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>butalbital<p>butalbital will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>carbamazepine<p>carbamazepine will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>cefadroxil<p>cefadroxil will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>cefamandole<p>cefamandole will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>cefpirome<p>cefpirome will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>ceftizoxime<p>ceftizoxime will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>cephalexin<p>cephalexin will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>chlorothiazide<p>chlorothiazide will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>chlorpromazine<p>celecoxib will increase the level or effect of chlorpromazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>chlorpropamide<p>celecoxib will increase the level or effect of chlorpropamide by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>chlorthalidone<p>chlorthalidone will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>choline magnesium trisalicylate<p>celecoxib will increase the level or effect of choline magnesium trisalicylate by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>cimetidine<p>cimetidine will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>creatine<p>creatine, celecoxib. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. (Theoretical interaction) Combination may have additive nephrotoxic effects.</p></li><li>cyclopenthiazide<p>cyclopenthiazide will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>danshen<p>celecoxib and danshen both increase  anticoagulation. Minor/Significance Unknown.</p></li><li>devil's claw<p>celecoxib and devil's claw both increase  anticoagulation. Minor/Significance Unknown.</p></li><li>dexfenfluramine<p>celecoxib will increase the level or effect of dexfenfluramine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>dextroamphetamine<p>celecoxib will increase the level or effect of dextroamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>dextromethorphan<p>celecoxib will increase the level or effect of dextromethorphan by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>diclofenac<p>celecoxib will increase the level or effect of diclofenac by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>diclofenac topical<p>diclofenac topical, celecoxib.
Either increases effects of the other by pharmacodynamic synergism. Minor/Significance Unknown. Although low, there is systemic exposure to diclofenac topical; theoretically, concomitant administration with systemic NSAIDS or aspirin may result in increased NSAID adverse effects.</p></li><li>diflunisal<p>celecoxib will increase the level or effect of diflunisal by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>disulfiram<p>disulfiram will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>divalproex sodium<p>divalproex sodium will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>donepezil<p>celecoxib will increase the level or effect of donepezil by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>encainide<p>celecoxib will increase the level or effect of encainide by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>eplerenone<p>celecoxib decreases effects of eplerenone by pharmacodynamic antagonism. Minor/Significance Unknown. NSAIDs decrease prostaglandin synthesis.</p></li><li>etodolac<p>celecoxib will increase the level or effect of etodolac by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>etoricoxib<p>celecoxib will increase the level or effect of etoricoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>etravirine<p>etravirine will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>felbamate<p>felbamate will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>fenbufen<p>celecoxib will increase the level or effect of fenbufen by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>fenoprofen<p>celecoxib will increase the level or effect of fenoprofen by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>fesoterodine<p>celecoxib will increase the level or effect of fesoterodine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>feverfew<p>celecoxib decreases effects of feverfew by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>fluconazole<p>fluconazole will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>fluphenazine<p>celecoxib will increase the level or effect of fluphenazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>flurbiprofen<p>celecoxib will increase the level or effect of flurbiprofen by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>fluvoxamine<p>celecoxib will increase the level or effect of fluvoxamine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>furosemide<p>celecoxib decreases effects of furosemide by pharmacodynamic antagonism. Minor/Significance Unknown. NSAIDs decrease prostaglandin synthesis.</p></li><li>galantamine<p>celecoxib will increase the level or effect of galantamine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>ganciclovir<p>celecoxib will increase the level or effect of ganciclovir by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>gentamicin<p>celecoxib increases levels of gentamicin by decreasing renal clearance. Minor/Significance Unknown. Interaction mainly occurs in preterm infants.</p></li><li>glycerol phenylbutyrate<p>glycerol phenylbutyrate decreases levels of celecoxib by affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown. Glycerol phenylbutyrate does not significantly affect the pharmacokinetics of celecoxib, a substrate of CYP2C9. Cmax and AUC for celecoxib were 13% and 8% lower than after administration of celecoxib alone.</p></li><li>hexobarbital<p>hexobarbital will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>hydrochlorothiazide<p>hydrochlorothiazide will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>hydrocodone<p>celecoxib decreases effects of hydrocodone by decreasing metabolism. Minor/Significance Unknown. Decreased conversion of hydrocodone to active metabolite morphine.</p></li><li>ibuprofen<p>celecoxib will increase the level or effect of ibuprofen by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>imidapril<p>celecoxib decreases effects of imidapril by pharmacodynamic antagonism. Minor/Significance Unknown. NSAIDs decrease prostaglandin synthesis.</p></li><li>indapamide<p>indapamide will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>indomethacin<p>celecoxib will increase the level or effect of indomethacin by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>itraconazole<p>itraconazole will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>kanamycin<p>celecoxib increases levels of kanamycin by decreasing renal clearance. Minor/Significance Unknown. Interaction mainly occurs in preterm infants.</p></li><li>ketoconazole<p>ketoconazole will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>ketoprofen<p>celecoxib will increase the level or effect of ketoprofen by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>ketorolac<p>celecoxib will increase the level or effect of ketorolac by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>ketorolac intranasal<p>celecoxib will increase the level or effect of ketorolac intranasal by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>leflunomide<p>leflunomide will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>loratadine<p>celecoxib will increase the level or effect of loratadine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>lornoxicam<p>celecoxib will increase the level or effect of lornoxicam by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>meclofenamate<p>celecoxib will increase the level or effect of meclofenamate by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>mefenamic acid<p>celecoxib will increase the level or effect of mefenamic acid by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>meloxicam<p>celecoxib will increase the level or effect of meloxicam by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>mephobarbital<p>mephobarbital will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>mesalamine<p>celecoxib will increase the level or effect of mesalamine by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>methyclothiazide<p>methyclothiazide will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>metolazone<p>metolazone will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>metronidazole<p>metronidazole will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>miconazole vaginal<p>miconazole vaginal will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>nabumetone<p>celecoxib will increase the level or effect of nabumetone by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>naproxen<p>celecoxib will increase the level or effect of naproxen by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>nateglinide<p>nateglinide will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>neomycin po<p>celecoxib increases levels of neomycin po by decreasing renal clearance. Minor/Significance Unknown. Interaction mainly occurs in preterm infants.</p></li><li>netilmicin<p>celecoxib increases levels of netilmicin by decreasing renal clearance. Minor/Significance Unknown. Interaction mainly occurs in preterm infants.</p></li><li>nilotinib<p>nilotinib will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>noni juice<p>celecoxib and noni juice both increase  serum potassium. Minor/Significance Unknown.</p></li><li>norfloxacin<p>norfloxacin, celecoxib. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of CNS stimulation/seizure.  Mechanism: Displacement of GABA from receptors in brain.</p></li><li>ofloxacin<p>ofloxacin, celecoxib. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of CNS stimulation/seizure.  Mechanism: Displacement of GABA from receptors in brain.</p></li><li>oxaprozin<p>celecoxib will increase the level or effect of oxaprozin by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>oxycodone<p>celecoxib decreases effects of oxycodone by decreasing metabolism. Minor/Significance Unknown. Decreased conversion of oxycodone to active metabolite morphine.</p></li><li>parecoxib<p>celecoxib will increase the level or effect of parecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>paromomycin<p>celecoxib increases levels of paromomycin by decreasing renal clearance. Minor/Significance Unknown. Interaction mainly occurs in preterm infants.</p></li><li>paroxetine<p>celecoxib will increase the level or effect of paroxetine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>pentobarbital<p>pentobarbital will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>perhexiline<p>celecoxib will increase the level or effect of perhexiline by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>perphenazine<p>celecoxib will increase the level or effect of perphenazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>phenobarbital<p>phenobarbital will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>piroxicam<p>celecoxib will increase the level or effect of piroxicam by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>primidone<p>primidone will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>prochlorperazine<p>celecoxib will increase the level or effect of prochlorperazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>promazine<p>celecoxib will increase the level or effect of promazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>promethazine<p>celecoxib will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>rifampin<p>rifampin will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>rifapentine<p>rifapentine will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>risperidone<p>celecoxib will increase the level or effect of risperidone by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>rose hips<p>rose hips will increase the level or effect of celecoxib by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>salicylates (non-asa)<p>celecoxib will increase the level or effect of salicylates (non-asa) by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>salsalate<p>celecoxib will increase the level or effect of salsalate by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>secobarbital<p>secobarbital will decrease the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>sitaxentan<p>sitaxentan will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>streptomycin<p>celecoxib increases levels of streptomycin by decreasing renal clearance. Minor/Significance Unknown. Interaction mainly occurs in preterm infants.</p></li><li>sulfamethoxazole<p>sulfamethoxazole will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>sulfasalazine<p>celecoxib will increase the level or effect of sulfasalazine by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>sulindac<p>celecoxib will increase the level or effect of sulindac by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>ticlopidine<p>ticlopidine will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>tobramycin<p>celecoxib increases levels of tobramycin by decreasing renal clearance. Minor/Significance Unknown. Interaction mainly occurs in preterm infants.</p></li><li>tolfenamic acid<p>celecoxib will increase the level or effect of tolfenamic acid by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>tolmetin<p>celecoxib will increase the level or effect of tolmetin by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>tolterodine<p>celecoxib will increase the level or effect of tolterodine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>triamterene<p>triamterene, celecoxib. Other (see comment). Minor/Significance Unknown. 
Comment: Risk of acute renal failure.  Mechanism: NSAIDs decrease prostaglandin synthesis, which normally protect against nephrotoxicity.<span><br><br></span>celecoxib increases toxicity of triamterene by pharmacodynamic antagonism. Minor/Significance Unknown. NSAIDs decrease prostaglandin synthesis, increasing the risk of nephrotoxicity.</p></li><li>trifluoperazine<p>celecoxib will increase the level or effect of trifluoperazine by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>tropisetron<p>celecoxib will increase the level or effect of tropisetron by  affecting hepatic enzyme CYP2D6 metabolism. Minor/Significance Unknown.</p></li><li>valganciclovir<p>celecoxib will increase the level or effect of valganciclovir by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>valproic acid<p>valproic acid will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>vancomycin<p>celecoxib increases levels of vancomycin by decreasing renal clearance. Minor/Significance Unknown. Interaction mainly occurs in neonates.</p></li><li>voriconazole<p>voriconazole will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li><li>willow bark<p>celecoxib will increase the level or effect of willow bark by  acidic (anionic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>zafirlukast<p>zafirlukast will increase the level or effect of celecoxib by  affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.</p></li>